Follow
Heribert Playa-Albinyana
Heribert Playa-Albinyana
PhD Student, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
Verified email at recerca.clinic.cat
Title
Cited by
Cited by
Year
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia
F Nadeu, R Royo, R Massoni-Badosa, H Playa-Albinyana, B Garcia-Torre, ...
Nature medicine 28 (8), 1662-1671, 2022
652022
Systems biology drug screening identifies statins as enhancers of current therapies in chronic lymphocytic leukemia
N Gimenez, R Tripathi, A Giró, L Rosich, M López-Guerra, I López-Oreja, ...
Scientific Reports 10 (1), 22153, 2020
172020
Identification by mass spectrometry and immunoblotting of xenogeneic antigens in the N- and O-glycomes of porcine, bovine and equine heart tissues
C Jin, RM Cherian, J Liu, H Playà-Albinyana, C Galli, NG Karlsson, ...
Glycoconjugate journal 37, 485-498, 2020
132020
A novel patient-derived 3D model recapitulates mantle cell lymphoma lymph node signaling, immune profile and in vivo ibrutinib responses
F Araujo-Ayala, C Dobaño-López, JG Valero, F Nadeu, F Gava, C Faria, ...
Leukemia 37 (6), 1311-1323, 2023
72023
Generation of Richter transformation models throughout chronic lymphocytic leukemia patient-derived Xenografts: a clonal evolution model
H Playa-Albinyana, F Arenas, R Royo, A Giró, I López, M Lopez-Guerra, ...
Blood 140 (Supplement 1), 1534-1535, 2022
42022
BCL3 rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases
A Carbo-Meix, F Guijarro, L Wang, M Grau, R Royo, G Frigola, ...
Haematologica 109 (2), 493, 2024
32024
Challenges with approved targeted therapies against recurrent mutations in CLL: A place for new actionable targets
I López-Oreja, H Playa-Albinyana, F Arenas, M López-Guerra, D Colomer
Cancers 13 (13), 3150, 2021
32021
IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia
C Syrykh, B Pons-Brun, N Russiñol, H Playa-Albinyana, T Baumann, ...
Blood Advances 7 (23), 7384-7391, 2023
22023
SF3B1 mutation–mediated sensitization to H3B-8800 splicing inhibitor in chronic lymphocytic leukemia
I López-Oreja, A Gohr, H Playa-Albinyana, A Giró, F Arenas, M Higashi, ...
Life Science Alliance 6 (11), 2023
22023
Chronic lymphocytic leukemia patient-derived xenografts recapitulate clonal evolution to Richter transformation
H Playa-Albinyana, F Arenas, R Royo, A Giró, I López-Oreja, M Aymerich, ...
Leukemia, 1-13, 2023
12023
Immunocompetent 3d follicular lymphoma model: A Preclinical tool to design tailored Immunotherapies
C Dobaño-López, JG Valero, F Araujo-Ayala, F Nadeu, F Gava, C Faria, ...
Blood 140 (Supplement 1), 9279-9280, 2022
12022
Advantages and disadvantages of mouse models of chronic lymphocytic leukemia in drug discovery
H Playa-Albinyana, F Arenas, D Colomer
Expert Opinion on Drug Discovery 16 (10), 1085-1090, 2021
12021
Network-Based Drug Discovery Identifies Statins as a Repurposing Agent to Improve Activity of Current Therapies in Chronic Lymphocytic Leukemia.
N Gimenez, R Tripathi, A Giró, L Rosich, M López-Guerra, I Lopez-Oreja, ...
12020
Combination of Ibrutinib and Nivolumab Overcomes Ibrutinib Resistance in a Novel Patient-Derived Mantle Cell Lymphoma 3D Model
F Araujo-Ayala, C Dobaño-López, JG Valero, F Nadeu, F Gava, C Faria, ...
Blood 140 (Supplement 1), 1323-1324, 2022
2022
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia
R Massoni-Badosa, H Playa-Albinyana, B García Torre, M Duran-Ferrer, ...
Nature Portfolio, 2022
2022
Supplementary files of the article" Detection of early seeding of Richter transformation in chronic lymphocytic leukemia"[Dataset]
F Nadeu, R Royo, R Massoni-Badosa, H Playa-Albinyana, B Garcia-Torre, ...
Springer Nature, 2022
2022
Patient-derived xenograft models confirm the early seeding and recapitulate the evolution of Richter transformation
H Playa-Albinyana
The system can't perform the operation now. Try again later.
Articles 1–17